Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05614128 · ClinicalTrials.gov registry record
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT05614128: Clinical Trial study, sponsored by Vanderbilt University Medical Center.
NCT05614128 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05614128 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn about chronic inflammatory demyelinating polyneuropathy. The main question the investigators would like to answer is 1) can skin biopsy identify demyelination better than nerve conduction studies (electrical tests of the nerves)? and 2) how do nerves improve after treatment in CIDP? Participants will be asked to undergo skin biopsy of the finger at baseline and at 3 months and 6 months after treatment with IVIG (which is the FDA approved treatment for CIDP).
Primary Outcome
Number of nerve fibers with demyelination visualized under microscopy will be calculated per biopsy.
Interventions
- OTHER IVIg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2024-09-19 |
Why NCT05614128 stopped before completion
NCT05614128 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which IVIg is the first listed.
NCT05614128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05614128 about?
NCT05614128 is a clinical study titled "Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP". The goal of this observational study is to learn about chronic inflammatory demyelinating polyneuropathy. The main question the investigators would like to answer is 1) can skin biopsy identify demyelination better than nerve conduction studies (electrical tests of the nerves)? and 2) how do nerves ...
What is the current status of trial NCT05614128?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2023-02-28. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT05614128?
The interventions under investigation include: IVIg (OTHER).
Who is sponsoring clinical trial NCT05614128?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI